No Data
Bionomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Bionomics Receives Notice Of Allowance For US Patent On Substituted-N-Heteroaryl Compounds For Cognitive Function And CNS Disorders
ADRs Close Lower; Bionomics Ltd. Declines 18%
Bionomics Poised for Phase 3 Success With BNC210 Following Favorable FDA Meeting: A Strong Buy Recommendation
Bionomics Announces Successful End-of-Phase 2 Meeting With the FDA on the Development of BNC210 in Post-Traumatic Stress Disorder
No Data